Pregnant after the first dose of COVID-19 vaccine—now what?
Two of the COVID-19 vaccines currently authorized for emergency use by the U.S. Food and Drug Administration require two doses to reach the full level of...
Two of the COVID-19 vaccines currently authorized for emergency use by the U.S. Food and Drug Administration require two doses to reach the full level of...
In rare cases, people who have been fully vaccinated against COVID and are immune to the virus can nevertheless develop the disease. New findings from The...
A growing number of young Australian women are at increased risk of having children born with impaired neurological conditions, due to poor iodine intake.
Animals use their sense of smell to navigate the world—to find food, sniff out mates and smell danger. But when a hungry animal smells food and...
A new study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes—immune system cells also known as helper T cells—produced by people who have...
With an artificial intelligence (AI) method developed by researchers at Aalto University and University of Helsinki, researchers can now link immune cells to their targets and...
Apic Bio, a gene therapy company developing treatment options for patients with rare genetic diseases and co-founded by UMass Medical School’s Robert H. Brown Jr., DPhil,...
University of Manchester scientists have cast new light on how our skin repairs itself, bringing the possibility of regeneration of the organ a step closer.
Scientists have identified a potential drug target for treating obesity and eating disorders such as anorexia nervosa, a condition for which no therapeutics are currently available.
A multidisciplinary team of researchers from Duke-NUS Medical School and the Agency for Science, Technology and Research (A*STAR) in Singapore has discovered a new mitochondrial peptide...